ALK-Abello A/S (AKBLF)
38.89
0.00 (0.00%)
USD |
OTCM |
May 19, 16:00
ALK-Abello Profit Margin (Quarterly) : 24.68% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk A/S | 50.15% |
| H. Lundbeck A/S | 23.60% |
| AstraZeneca PLC | 20.15% |
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.99% |
| Return on Assets | 14.86% |
| Return on Invested Capital | 19.32% |
| Gross Profit Margin (Quarterly) | 69.34% |
| Operating Margin (Quarterly) | 32.19% |
| Return on Net Operating Assets | 18.58% |